Feasibility of cardiovascular risk screening in Portuguese community pharmacies

Autor: Anabela A. Fonseca, Isabel Vitória Figueiredo, Margarida Castel-Branco, Tácio de Mendonça Lima
Jazyk: angličtina
Rok vydání: 2021
Předmět:
obesity
Cross-sectional study
pharmacists
Pharmaceutical Science
cross-sectional studies
mesh:Risk Factors
Pharmacy
heart disease risk factors
Pharmacists
030226 pharmacology & pharmacy
0302 clinical medicine
mesh:Heart Disease Risk Factors
Risk Factors
sedentary behavior
mesh:Sedentary Behavior
Medicine
risk factors
mesh:Hypertension
dyslipidemias
Original Research
mesh:Obesity
feasibility studies
Smoking
mesh:Portugal
risk assessment
mesh:Feasibility Studies
Cardiovascular Diseases
Hypertension
mesh:Cardiovascular Diseases
mesh:Smoking
Risk assessment
medicine.medical_specialty
hypertension
mesh:Risk Assessment
Pharmacist
RM1-950
Risk Assessment
smoking
03 medical and health sciences
Pharmacotherapy
pharmacies
pharmaceutical services
Pharmacy and materia medica
Obesity
mesh:Pharmacists
Dyslipidemias
Pharmacies
Portugal
business.industry
mesh:Pharmacies
medicine.disease
Impaired fasting glucose
portugal
cardiovascular diseases
RS1-441
mesh:Pharmaceutical Services
Cross-Sectional Studies
mesh:Dyslipidemias
Heart Disease Risk Factors
mesh:Cross-Sectional Studies
Family medicine
Pharmaceutical Services
Feasibility Studies
Therapeutics. Pharmacology
Sedentary Behavior
business
Dyslipidemia
Zdroj: Pharmacy Practice
Pharmacy Practice, Vol 19, Iss 2, p 2255 (2021)
Pharmacy Practice (Granada) v.19 n.2 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
ISSN: 1886-3655
1885-642X
Popis: Background: Cardiovascular disease (CVD) remains the leading cause of human mortality. As highly accessible and qualified health professionals, community pharmacists can be included in the early detection of patients at risk for CVD by implementing CVD screening programs. Objective: To assess the feasibility of CVD risk screening services in Portuguese community pharmacies from the evaluation of customers acceptability. Methods: A cross-sectional study was conducted in a community pharmacy in Portugal. The purpose of entering the pharmacy was recorded for all customers. Afterwards, the customers were invited to be interviewed by the pharmacist, who registered their willingness to participate and collected the participants’ data and biochemical and physical parameters to assess their CV risk by applying the Systematic COronary Risk Evaluation (SCORE) model. For the participants who were not eligible for the SCORE-based risk assessment, the pharmacist considered the major modifiable CVD risk factors - hypertension, dyslipidemia, smoking habits, obesity, impaired fasting glucose and sedentary behavior - according to the ESC guidelines. Results: Picking up medication was the most prevalent reason 69.8% (n=1,600) for entering the pharmacy, and among the contacted customers, 56.4% (n=621) agreed to have their CVD risk assessed. Of the 588 participants, 56.6% (n=333) were already on CV pharmacotherapy and were therefore not eligible for screening. Of the 43.4% (n=255) CV pharmacotherapy-naïve participants, 94.9% (n=242) were screened with at least one CVD risk factor; 52.9% (n=135) were not eligible for the SCORE assessment, of which 92.6% (n=125) presented CVD risk factors. Of the 120 SCORE eligible participants, 80.0% (n=96) were at least at moderate risk of CVD. Conclusions: We determined the feasibility of CVD risk screening in Portuguese community pharmacies, as we found high customer acceptability, noted the reasons for nonattendance, and found a high prevalence of CVD risk factors in at-risk patients. This is an opportunity for Portuguese community pharmacists to take a leading role in the early detection of CVD. 3910-3178-31BA | MARIA MARGARIDA COUTINHO DE SEABRA CASTEL-BRANCO CAETANO info:eu-repo/semantics/publishedVersion
Databáze: OpenAIRE